Table 4_Hekun decoction versus Femoston for women with amnestic mild cognitive impairment in early menopause: a randomized, three-arm, double-blind clinical trial.docx

Background<p>Amnestic mild cognitive impairment (aMCI), a prodromal stage of Alzheimer’s disease (AD), carries a high risk of progression to dementia. However, few clinical trials have focused on interventions to delay this progression. Hekun Decoction, an herbal-based oral medicine, has shown...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Ziqi Zhai (18055509) (author)
Andere auteurs:	Guangyao Lin (15270472) (author), Siru Chen (12535119) (author), Huicong Liu (1513414) (author), Rui Yuan (615737) (author), Xianwei Gao (22234654) (author), Xiaorong Ni (17830436) (author), Mingjie Shen (9379710) (author), Haiying Fan (267645) (author), Wenjun Wang (314231) (author), Yan Zhao (58882) (author), Yan Wu (70890) (author), Chao Gu (402478) (author), Chao Cong (14577518) (author), Shan Xiao (3117867) (author), Yue Zhang (30585) (author), Jingchang Zhao (9192073) (author), Jiayao Xu (1421440) (author), Ye Wang (41998) (author), Jie Chen (5892) (author), Yishuang Chen (22234657) (author), Yan Zong (6274541) (author), Qianjue Tang (22234660) (author), Shengnan Li (345816) (author), Zhijie Zhang (227551) (author), Lianwei Xu (16857051) (author)
Gepubliceerd in:	2025
Onderwerpen:	Neurology and Neuromuscular Diseases amnestic mild cognitive impairment Hekun decoction early menopausal women Alzheimer’s disease clinical trial
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Table 4_Hekun decoction versus Femoston for women with amnestic mild cognitive impairment in early menopause: a randomized, three-arm, double-blind clinical trial.docx

Gelijkaardige items